Search

everythinglearnresearchcommunity

for

Search:↓

QR678 and QR678 Neo treatments, combined with corticosteroid injections, work better for alopecia areata than corticosteroid injections alone.

The trial on testosterone replacement therapy in older men faced concerns due to prostate cancer risk.

Adults with Tatton-Brown-Rahman syndrome may have serious heart problems and need lifelong heart monitoring.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

The serum improves facial skin quality safely and effectively.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Most patients with alopecia areata did not achieve lasting hair regrowth despite treatment.

Non-blinded assessors tend to overestimate effects in trials by about 29%.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Genetic discoveries are leading to new treatments for alopecia areata.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

A botanical extract was found to be a safe treatment that may prevent hair loss in chemotherapy patients.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

Beard alopecia areata causes patchy beard hair loss, often treatable with janus kinase inhibitors.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

AMT® shows promise as a safe and effective treatment for early-stage knee osteoarthritis.

NXC736 significantly reduced hair loss in mice with alopecia areata.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

Off-label treatments are heavily used for alopecia areata due to limited approved options.

Farudodstat may effectively treat alopecia areata by protecting hair follicles without harmful effects.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.